Since Christmas is almost upon us and time is tight, let’s call this business in brief, eh? You can always follow the bouncing hyperlinks if you want to know more!
Okay … election deadlines are coming up for MediciNova’s proposed acquisition of Island-based biotech Avigen. The deadline is 5 p.m. (Eastern Standard Time) on Wednesday, and earlier potentially if you bought your stock through a bank, broker or other nominee. The press release on this one is on CNNMoney.com.
UTStarcom has tracked down a new chief financial officer – in China. Kenneth Luk will be based in China, where the networking equipment maker does a lot of its business, according to the San Francisco Business Times.
And last but not least, the folks at InSite Vision have announced they’re advancing a new eye drug aimed at diminishing the pain and swelling caused by cataract surgery, says the San Francisco Business Times. The topical anti-inflammatory treatment, ISV-303, heads into clinical studies once toxicology studies are completed in the first half of next year, the paper reports.